Single Dose of Psilocybin Linked to Lasting Anatomical Brain Changes
A small study published in Nature Communications reveals that a single 25mg dose of psilocybin, the active compound in magic mushrooms, can induce measurable anatomical changes in the human brain. Using diffusion tensor imaging, researchers observed that nerve tracts became denser and more robust, with effects persisting for at least one month. These structural alterations contrast with the neural degradation typically seen in aging and dementia. Participants also reported significant improvements in psychological insight, wellbeing, and mental flexibility. The study found a correlation between increased brain entropy immediately after ingestion and better long-term mental health outcomes, suggesting a psychobiological therapeutic mechanism. Prof Robin Carhart-Harris from the University of California, San Francisco, highlighted the rarity of such lasting structural changes from a single drug dose. While Prof Alex Kwan from Cornell University noted the findings align with mouse studies on neural plasticity, he cautioned that the small sample size and indirect nature of the imaging technology limit definitive conclusions. Nevertheless, the research provides compelling preliminary evidence linking psychedelic-induced brain plasticity to improved mental health.
Wire timeline
Single Dose of Psilocybin Linked to Lasting Anatomical Brain Changes
A small study published in Nature Communications reveals that a single 25mg dose of psilocybin, the active compound in magic mushrooms, can induce measurable anatomical changes in the human brain. Using diffusion tensor imaging, researchers observed that nerve tracts became denser and more robust, with effects persisting for at least one month. These structural alterations contrast with the neural degradation typically seen in aging and dementia. Participants also reported significant improvements in psychological insight, wellbeing, and mental flexibility. The study found a correlation between increased brain entropy immediately after ingestion and better long-term mental health outcomes, suggesting a psychobiological therapeutic mechanism. Prof Robin Carhart-Harris from the University of California, San Francisco, highlighted the rarity of such lasting structural changes from a single drug dose. While Prof Alex Kwan from Cornell University noted the findings align with mouse studies on neural plasticity, he cautioned that the small sample size and indirect nature of the imaging technology limit definitive conclusions. Nevertheless, the research provides compelling preliminary evidence linking psychedelic-induced brain plasticity to improved mental health.
Slashdot